Your browser doesn't support javascript.
loading
Symptomatic periesophageal vagal nerve injury by different energy sources during atrial fibrillation ablation.
Miyazaki, Shinsuke; Kobori, Atsushi; Jo, Hikari; Keida, Takehiko; Yoshitani, Kazuyasu; Mukai, Moe; Sagawa, Yuichiro; Asakawa, Tetsuya; Sato, Eiji; Yamao, Kazuya; Horie, Tomoki; Manita, Mamoru; Fukaya, Hidehira; Hayashi, Hidemori; Tanimoto, Kojiro; Iwayama, Tadateru; Chiba, Suguru; Sato, Akinori; Sekiguchi, Yukio; Sugiura, Kenta; Iwai, Shinsuke; Isonaga, Yuhei; Miwa, Naoyuki; Kato, Nobutaka; Inaba, Osamu; Hirota, Takayoshi; Nagata, Yasutoshi; Ono, Yuichi; Hachiya, Hitoshi; Yamauchi, Yasuteru; Goya, Masahiko; Nitta, Junichi; Tada, Hiroshi; Sasano, Tetsuo.
Afiliación
  • Miyazaki S; Department of Cardiovascular Medicine, Tokyo Medical and Dental University, Tokyo, Japan.
  • Kobori A; Department of Cardiovascular Medicine, Kobe City Medical Center General Hospital, Hyogo, Japan.
  • Jo H; Department of Cardiology, National Hospital Organization Higashi-Hiroshima Medical Center, Hiroshima, Japan.
  • Keida T; Department of Cardiology, Edogawa Hospital, Tokyo, Japan.
  • Yoshitani K; Department of Cardiology, Hyogo Prefectural Amagasaki General Medical Center, Hyogo, Japan.
  • Mukai M; Department of Cardiovascular Medicine, Faculty of Medical Sciences, University of Fukui, Fukui, Japan.
  • Sagawa Y; Department of Cardiology, Japanese Red Cross Yokohama City Bay Hospital, Kanagawa, Japan.
  • Asakawa T; Department of Cardiology, Yamanashi Kosei Hospital, Yamanashi, Japan.
  • Sato E; Department of Cardiovascular Medicine, Sendai City Hospital, Miyagi, Japan.
  • Yamao K; Department of Cardiology, Ome Municipal General Hospital, Tokyo, Japan.
  • Horie T; Department of Cardiology, Japanese Red Cross Musashino Hospital, Tokyo, Japan.
  • Manita M; Department of Cardiology, Naha City Hospital, Okinawa, Japan.
  • Fukaya H; Department of Cardiovascular Medicine, Kitasato University School of Medicine, Kanagawa, Japan.
  • Hayashi H; Department of Cardiovascular Biology and Medicine, Juntendo University, Tokyo, Japan.
  • Tanimoto K; Department of Cardiology, National Hospital Organization Tokyo Medical Center, Tokyo, Japan.
  • Iwayama T; Department of Cardiology, Okitama Public General Hospital, Yamagata, Japan.
  • Chiba S; Department of Cardiology, Urasoe General Hospital, Okinawa, Japan.
  • Sato A; Cardiovascular Center, Tachikawa General Hospital, Niigata, Japan.
  • Sekiguchi Y; Department of Cardiology, Sakakibara Heart Institute, Tokyo, Japan.
  • Sugiura K; Department of Cardiology and Geriatrics, Kochi University, Kochi, Japan.
  • Iwai S; Department of Cardiology, Hiratsuka Kyosai Hospital, Kanagawa, Japan.
  • Isonaga Y; Department of Cardiology, Japanese Red Cross Saitama Hospital, Saitama, Japan.
  • Miwa N; Cardiovascular Center, Tsuchiura Kyodo Hospital, Ibaraki, Japan.
  • Kato N; Department of Cardiology, Hiratsuka Kyosai Hospital, Kanagawa, Japan.
  • Inaba O; Department of Cardiology, Japanese Red Cross Saitama Hospital, Saitama, Japan.
  • Hirota T; Department of Cardiology and Geriatrics, Kochi University, Kochi, Japan.
  • Nagata Y; Department of Cardiology, Japanese Red Cross Musashino Hospital, Tokyo, Japan.
  • Ono Y; Department of Cardiology, Ome Municipal General Hospital, Tokyo, Japan.
  • Hachiya H; Cardiovascular Center, Tsuchiura Kyodo Hospital, Ibaraki, Japan.
  • Yamauchi Y; Department of Cardiology, Japanese Red Cross Yokohama City Bay Hospital, Kanagawa, Japan.
  • Goya M; Department of Cardiovascular Medicine, Tokyo Medical and Dental University, Tokyo, Japan.
  • Nitta J; Department of Cardiology, Sakakibara Heart Institute, Tokyo, Japan.
  • Tada H; Department of Cardiovascular Medicine, Faculty of Medical Sciences, University of Fukui, Fukui, Japan.
  • Sasano T; Department of Cardiovascular Medicine, Tokyo Medical and Dental University, Tokyo, Japan.
Front Cardiovasc Med ; 10: 1278603, 2023.
Article en En | MEDLINE | ID: mdl-37965084
ABSTRACT

Background:

Symptomatic gastric hypomotility (SGH) is a rare but major complication of atrial fibrillation (AF) ablation, but data on this are scarce.

Objective:

We compared the clinical course of SGH occurring with different energy sources.

Methods:

This multicenter study retrospectively collected the characteristics and clinical outcomes of patients with SGH after AF ablation.

Results:

The data of 93 patients (67.0 ± 11.2 years, 68 men, 52 paroxysmal AF) with SGH after AF ablation were collected from 23 cardiovascular centers. Left atrial (LA) ablation sets included pulmonary vein isolation (PVI) alone, a PVI plus a roof-line, and an LA posterior wall isolation in 42 (45.2%), 11 (11.8%), and 40 (43.0%) patients, respectively. LA ablation was performed by radiofrequency ablation, cryoballoon ablation, or both in 38 (40.8%), 38 (40.8%), and 17 (18.3%) patients, respectively. SGH diagnoses were confirmed at 2 (1-4) days post-procedure, and 28 (30.1%) patients required re-hospitalizations. Fasting was required in 81 (92.0%) patients for 4 (2.5-5) days; the total hospitalization duration was 11 [7-19.8] days. After conservative treatment, symptoms disappeared in 22.3% of patients at 1 month, 48.9% at 2 months, 57.6% at 3 months, 84.6% at 6 months, and 89.7% at 12 months, however, one patient required surgery after radiofrequency ablation. Symptoms persisted for >1-year post-procedure in 7 patients. The outcomes were similar regardless of the energy source and LA lesion set.

Conclusions:

The clinical course of SGH was similar regardless of the energy source. The diagnosis was often delayed, and most recovered within 6 months, yet could persist for over 1 year in 10%.
Palabras clave